Works matching IS 2160763X AND DT 2022 AND VI 11 AND IP 6

Results: 11

Evaluation of Pharmacokinetics and Safety With Bioequivalence of Anastrozole in Healthy Chinese Volunteers: Bioequivalence Study Findings.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 6, p. 687, doi. 10.1002/cpdd.1099

By:

Wang, Ying;
Wang, Tongtong;
Fang, Han;
Huang, Hui;
Fang, Lijuan;
Zhang, XuanGuo

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2022, v. 11, n. 6, p. 683, doi. 10.1002/cpdd.828
Publication type:: Article

Pharmacokinetics and Bioequivalence Evaluation of 2 Olmesartan Medoxomil and Amlodipine Besylate Fixed‐Dose Combination Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 6, p. 761, doi. 10.1002/cpdd.1086

By:

Li, Xinjing;
Mo, Enpan;
Chen, Lin

Publication type:

Article

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Isavuconazonium Sulfate in Healthy Adult Japanese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 6, p. 744, doi. 10.1002/cpdd.1079

By:

Shirae, Shinichiro;
Ose, Atsushi;
Kumagai, Yuji

Publication type:

Article

Pharmacokinetics, Bioequivalence, and Safety Studies of Amlodipine Besylate in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 6, p. 717, doi. 10.1002/cpdd.1064

By:

Chen, Bin;
Chen, ZhiMin;
Lv, DongQing;
Sun, Yuan;
Chen, HuaFang

Publication type:

Article

Evaluating the Safety, Tolerability, and Disposition of Trazpiroben, a D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist: Phase I Single‐ and Multiple‐Ascending Dose Studies in Healthy Japanese Participants.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 6, p. 695, doi. 10.1002/cpdd.1057

By:

Yamaguchi, Takayoshi;
Kudou, Kentarou;
Okamoto, Hiroyuki;
Chen, Chunlin;
Whiting, Roger;
Sekino, Hisakuni

Publication type:

Article

Pharmacokinetics, Safety, and Tolerability of NPC‐21, an Anti‐Cytomegalovirus Monoclonal Antibody, in Healthy Japanese and White Adult Men: A Randomized, Placebo‐Controlled, First‐in‐Human Phase 1 Study.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 6, p. 707, doi. 10.1002/cpdd.1065

By:

Furihata, Kenichi;
Hamada, Izumi;
Niwa, Takuro;
Watanabe, Tatsuya;
Ezoe, Sachiko

Publication type:

Article

Four‐Way Crossover Phase 1 Thorough QT Study to Assess Cardiac Safety of Domperidone and Consideration for Design and Conduct of QT/QTc Study in China.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 6, p. 734, doi. 10.1002/cpdd.1072

By:

Wang, Fangfang;
Nie, Jing;
Yang, Li;
Yang, Zhenhua;
Xu, Lin;
Wang, Liqun;
Liao, Huimin;
Li, Mengyu;
Wang, Ping;
Li, Gailing;
Li, Haiyan

Publication type:

Article

Similar Pharmacokinetics and Pharmacodynamics of Biosimilar SAR342434 Insulin Lispro and Japan‐Approved Humalog Insulin Lispro in Healthy Japanese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 6, p. 754, doi. 10.1002/cpdd.1068

By:

Shiramoto, Masanari;
Yoshihara, Tatsuya;
Schmider, Wolfgang;
Takahashi, Yoshinori;
Nowotny, Irene;
Kajiwara, Miyuki;
Muto, Hideya

Publication type:

Article

Assessment of Effects of Investigational TAK‐931, an Oral Cell Division Cycle 7 Kinase Inhibitor on the QTc Intervals in Patients With Advanced Solid Tumors.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 6, p. 770, doi. 10.1002/cpdd.1075

By:

Zhou, Xiaofei;
Diderichsen, Paul Matthias;
Gupta, Neeraj

Publication type:

Article

Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 6, p. 724, doi. 10.1002/cpdd.1049

By:

Chen, Lu;
Li, Lixian;
Chen, Wanyi

Publication type:

Article